Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Susan Lana

Concepts (245)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Dog Diseases
42
2025
140
6.520
Why?
Osteosarcoma
15
2022
100
2.600
Why?
Dogs
45
2025
517
1.790
Why?
Lymphoma
11
2021
251
1.510
Why?
Bone Neoplasms
10
2022
272
1.420
Why?
Cyclophosphamide
6
2019
275
1.000
Why?
Lymphoma, B-Cell
4
2019
150
0.850
Why?
Doxorubicin
8
2019
416
0.810
Why?
Hemangiosarcoma
3
2013
27
0.710
Why?
Cats
6
2017
226
0.640
Why?
Antineoplastic Agents, Alkylating
2
2017
76
0.560
Why?
Cat Diseases
5
2006
37
0.490
Why?
Animals
52
2025
38107
0.460
Why?
Carboplatin
2
2021
168
0.430
Why?
Maxillary Neoplasms
1
2014
9
0.430
Why?
Skull Neoplasms
1
2014
20
0.430
Why?
Mandibular Neoplasms
1
2014
23
0.420
Why?
Abetalipoproteinemia
1
2013
4
0.410
Why?
Antineoplastic Combined Chemotherapy Protocols
4
2019
1998
0.370
Why?
Mast-Cell Sarcoma
3
2010
9
0.360
Why?
Extremities
3
2022
142
0.340
Why?
Carcinoma
4
2006
225
0.330
Why?
Cisplatin
2
2004
347
0.300
Why?
Skin Neoplasms
4
2006
806
0.270
Why?
Sarcoma
4
2023
209
0.270
Why?
Antineoplastic Agents
7
2015
2219
0.260
Why?
Splenic Neoplasms
1
2007
6
0.260
Why?
Etoposide
1
2007
169
0.250
Why?
Disease-Free Survival
4
2019
778
0.240
Why?
Administration, Oral
4
2017
872
0.240
Why?
Head and Neck Neoplasms
1
2012
563
0.240
Why?
Thymoma
1
2006
38
0.240
Why?
Matrix Metalloproteinase 2
3
2002
57
0.240
Why?
Receptors, Antigen
1
2006
15
0.240
Why?
Lymphoma, T-Cell
2
2021
31
0.240
Why?
Mediastinal Neoplasms
1
2006
54
0.230
Why?
Soft Tissue Neoplasms
2
2023
133
0.230
Why?
Matrix Metalloproteinase 9
3
2002
128
0.230
Why?
Adenocarcinoma, Follicular
1
2025
43
0.230
Why?
Complementary Therapies
1
2006
93
0.220
Why?
Carcinoma, Neuroendocrine
1
2025
38
0.220
Why?
Half-Life
3
2017
157
0.220
Why?
Gene Rearrangement
1
2006
156
0.220
Why?
Nose Neoplasms
1
2004
22
0.210
Why?
Female
35
2025
79499
0.210
Why?
Vincristine
4
2019
148
0.200
Why?
Male
34
2025
73396
0.200
Why?
Gene Expression Regulation, Neoplastic
8
2025
1432
0.200
Why?
Pets
2
2021
28
0.200
Why?
Area Under Curve
2
2017
335
0.200
Why?
Neoplasms
4
2007
2954
0.200
Why?
Prednisone
4
2019
229
0.200
Why?
Histiocytoma, Malignant Fibrous
1
2023
6
0.200
Why?
Treatment Outcome
9
2022
11821
0.190
Why?
Brain Death
1
2023
59
0.190
Why?
Flow Cytometry
4
2019
1163
0.190
Why?
Combined Modality Therapy
6
2021
1271
0.180
Why?
Pathology, Veterinary
1
2021
2
0.180
Why?
Immunophenotyping
4
2021
324
0.170
Why?
Veterinarians
1
2021
12
0.170
Why?
Thyroid Neoplasms
1
2025
380
0.170
Why?
Wilms Tumor
1
2022
91
0.170
Why?
Analgesia
1
2022
106
0.160
Why?
Tumor Suppressor Protein p53
2
2023
530
0.160
Why?
Carcinoma, Transitional Cell
1
2021
70
0.160
Why?
Immunity, Humoral
1
2021
121
0.160
Why?
Neoplasm Staging
5
2010
1488
0.160
Why?
Tissue and Organ Procurement
1
2023
305
0.150
Why?
Anemia
2
2013
190
0.150
Why?
Tobacco Smoking
1
2019
29
0.150
Why?
Mutation, Missense
1
2021
334
0.150
Why?
Retrospective Studies
13
2022
17438
0.150
Why?
Goals
1
2021
187
0.150
Why?
Italy
4
2023
118
0.150
Why?
Sirolimus
1
2021
282
0.150
Why?
Veterinary Medicine
1
2019
12
0.140
Why?
Smokers
1
2019
139
0.140
Why?
Vaping
1
2019
81
0.140
Why?
Survival Analysis
6
2011
1378
0.140
Why?
Urinary Bladder Neoplasms
1
2021
259
0.130
Why?
Electronic Nicotine Delivery Systems
1
2019
112
0.130
Why?
Nasopharyngeal Neoplasms
1
1997
21
0.130
Why?
Kidney Neoplasms
1
2022
419
0.130
Why?
Injections, Intraperitoneal
1
2017
115
0.130
Why?
Lymph Nodes
3
2016
511
0.130
Why?
Carcinoma, Squamous Cell
2
2004
628
0.130
Why?
Pain
2
2022
790
0.130
Why?
Biomarkers
3
2008
4340
0.130
Why?
Biological Availability
1
2017
146
0.120
Why?
Magnetic Resonance Imaging
2
2022
3926
0.120
Why?
Administration, Intravenous
1
2017
172
0.120
Why?
Prognosis
6
2011
4351
0.120
Why?
Prospective Studies
3
2021
8123
0.110
Why?
Hospice Care
1
2019
230
0.110
Why?
Immunity, Innate
1
2021
844
0.110
Why?
Proto-Oncogene Proteins c-bcl-2
1
2016
237
0.110
Why?
Drug Administration Schedule
3
2014
790
0.110
Why?
Proto-Oncogene Proteins c-myc
1
2016
157
0.110
Why?
Alkaline Phosphatase
1
2015
144
0.100
Why?
Acanthocytes
1
2013
1
0.100
Why?
Tandem Mass Spectrometry
1
2017
576
0.100
Why?
Lymphoma, Large B-Cell, Diffuse
1
2016
195
0.100
Why?
Gene Expression Regulation, Enzymologic
1
2015
266
0.100
Why?
Radiotherapy
1
2014
209
0.100
Why?
Survival Rate
5
2021
2092
0.100
Why?
Polymerase Chain Reaction
2
2006
1031
0.100
Why?
Fas Ligand Protein
1
2012
61
0.090
Why?
Digestion
1
2012
17
0.090
Why?
Fabaceae
1
2012
12
0.090
Why?
Animal Feed
1
2012
50
0.090
Why?
Statistics, Nonparametric
2
2011
426
0.090
Why?
Infusions, Intravenous
2
2011
432
0.090
Why?
Genes, MHC Class II
1
2011
77
0.080
Why?
Delayed-Action Preparations
2
2004
192
0.080
Why?
Spectrometry, Mass, Electrospray Ionization
1
2011
175
0.080
Why?
Stromal Cells
2
2002
123
0.080
Why?
Random Allocation
1
2011
366
0.080
Why?
Genetic Therapy
1
2012
303
0.080
Why?
Radiography
1
2012
861
0.070
Why?
Surveys and Questionnaires
3
2019
6073
0.070
Why?
Multivariate Analysis
2
2006
1543
0.070
Why?
Foodborne Diseases
1
2009
60
0.070
Why?
Chromosome Aberrations
1
2009
167
0.070
Why?
Lymphocytosis
1
2008
12
0.070
Why?
Glucose Transporter Type 1
1
2008
49
0.070
Why?
Lymphoproliferative Disorders
1
2008
59
0.070
Why?
Diagnosis, Differential
1
2012
1503
0.060
Why?
Microtubule-Associated Proteins
1
2008
187
0.060
Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2007
74
0.060
Why?
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
1
2007
143
0.060
Why?
Histocytochemistry
1
2006
77
0.060
Why?
Prevalence
2
2019
2861
0.060
Why?
Lomustine
1
2006
18
0.060
Why?
DNA, Neoplasm
1
2006
160
0.060
Why?
Sensitivity and Specificity
2
2009
1998
0.060
Why?
Lymphocyte Count
1
2006
167
0.060
Why?
Mycosis Fungoides
1
2006
63
0.060
Why?
Time Factors
5
2010
7109
0.060
Why?
Neoplasm Proteins
1
2008
444
0.050
Why?
Biomarkers, Tumor
3
2021
1339
0.050
Why?
Risk Factors
2
2021
10921
0.050
Why?
Prostaglandin-Endoperoxide Synthases
1
2004
76
0.050
Why?
Incidence
2
2005
2936
0.050
Why?
Fatty Acids, Omega-3
1
2006
145
0.050
Why?
Diet
1
2012
1273
0.050
Why?
Radiotherapy, Adjuvant
1
2004
222
0.050
Why?
Isoenzymes
1
2004
294
0.050
Why?
Anal Gland Neoplasms
1
2003
1
0.050
Why?
Lymphatic Metastasis
1
2005
335
0.050
Why?
Colorado
3
2019
4595
0.050
Why?
Case-Control Studies
3
2007
3647
0.050
Why?
Proto-Oncogene Proteins c-sis
1
2023
38
0.050
Why?
Mutation
2
2025
4093
0.050
Why?
CD8-Positive T-Lymphocytes
3
2021
931
0.050
Why?
Hospitals, Animal
1
2022
2
0.050
Why?
Hospitals, Teaching
1
2022
121
0.040
Why?
Chromium
1
2001
18
0.040
Why?
Attitude
1
2023
253
0.040
Why?
Thoracic Vertebrae
1
2022
90
0.040
Why?
Dietary Supplements
1
2006
587
0.040
Why?
Positron Emission Tomography Computed Tomography
1
2022
122
0.040
Why?
Information Systems
1
2021
58
0.040
Why?
Muscle Development
1
2021
114
0.040
Why?
Orosomucoid
1
2000
10
0.040
Why?
Attitude to Health
1
2023
421
0.040
Why?
Tissue Donors
1
2023
425
0.040
Why?
Genomics
1
2025
853
0.040
Why?
Carcinoma, Small Cell
1
2000
172
0.040
Why?
Chemotherapy, Adjuvant
1
2021
429
0.040
Why?
Necrosis
2
2012
243
0.040
Why?
Education, Veterinary
1
2019
7
0.040
Why?
Proto-Oncogene Proteins B-raf
1
2021
231
0.040
Why?
Iron
1
2001
359
0.040
Why?
Reproducibility of Results
1
2007
3416
0.040
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2022
344
0.040
Why?
Neoplasm Recurrence, Local
1
2006
1160
0.040
Why?
B-Lymphocytes
3
2011
887
0.040
Why?
Humans
8
2025
146342
0.030
Why?
Zinc
1
2001
310
0.030
Why?
TOR Serine-Threonine Kinases
1
2021
455
0.030
Why?
Ear, External
1
1997
22
0.030
Why?
Cryotherapy
1
1997
22
0.030
Why?
Adenocarcinoma
1
2004
927
0.030
Why?
Dermatologic Surgical Procedures
1
1997
25
0.030
Why?
Nose
1
1997
67
0.030
Why?
Tumor Microenvironment
1
2021
747
0.030
Why?
Texas
1
1997
280
0.030
Why?
Universities
1
2019
451
0.030
Why?
Smoking Cessation
1
2019
442
0.030
Why?
Transcription Factors
1
2023
1730
0.030
Why?
Transcriptome
1
2021
1068
0.030
Why?
Biopsy
1
1997
1075
0.030
Why?
Skin
1
1997
701
0.020
Why?
Immunohistochemistry
2
2008
1712
0.020
Why?
Predictive Value of Tests
2
2010
2113
0.020
Why?
Animal Nutritional Physiological Phenomena
1
2012
13
0.020
Why?
Curriculum
1
2019
1079
0.020
Why?
Cooking
1
2012
62
0.020
Why?
Antigens, CD34
1
2011
89
0.020
Why?
Cell Size
1
2011
95
0.020
Why?
Brain
1
2023
2991
0.020
Why?
Thiazoles
1
2010
139
0.020
Why?
Benzamides
1
2010
226
0.020
Why?
Cytogenetics
1
2009
12
0.020
Why?
Chromosomes, Mammalian
1
2009
28
0.020
Why?
Piperidines
1
2010
225
0.020
Why?
Feces
1
2012
496
0.020
Why?
Trisomy
1
2009
79
0.020
Why?
Cross-Sectional Studies
1
2019
5899
0.020
Why?
In Situ Hybridization, Fluorescence
1
2009
334
0.020
Why?
Body Weight
1
2012
968
0.020
Why?
Tumor Cells, Cultured
1
2009
882
0.020
Why?
Signal Transduction
1
2021
5246
0.020
Why?
Retinoblastoma Protein
1
2007
63
0.020
Why?
Double-Blind Method
1
2012
2070
0.020
Why?
Cell Line, Tumor
1
2015
3545
0.020
Why?
Survivors
1
2010
526
0.020
Why?
Gene Silencing
1
2007
200
0.010
Why?
Patient Selection
1
2010
728
0.010
Why?
Pyridines
1
2010
610
0.010
Why?
Hypoxia-Inducible Factor 1, alpha Subunit
1
2008
299
0.010
Why?
Recurrence
1
2008
1133
0.010
Why?
Kaplan-Meier Estimate
1
2007
970
0.010
Why?
Cyclooxygenase 2
1
2004
166
0.010
Why?
Anal Sacs
1
2003
1
0.010
Why?
United States
1
2021
16136
0.010
Why?
Apocrine Glands
1
2003
5
0.010
Why?
Apoptosis
1
2012
2439
0.010
Why?
Chromatography, High Pressure Liquid
1
2006
588
0.010
Why?
Sex Distribution
1
2003
382
0.010
Why?
Blotting, Western
1
2004
1177
0.010
Why?
Electrophoresis, Agar Gel
1
2000
26
0.010
Why?
Immunodiffusion
1
2000
13
0.010
Why?
Aged
1
2021
26432
0.010
Why?
Hyperinsulinism
1
2001
115
0.010
Why?
Glucose Tolerance Test
1
2001
360
0.010
Why?
Adolescent
1
2019
22557
0.010
Why?
CD4-Positive T-Lymphocytes
1
2006
1150
0.010
Why?
Palliative Care
1
2007
1032
0.010
Why?
Killer Cells, Natural
1
2001
481
0.010
Why?
Regression Analysis
1
2000
999
0.010
Why?
Adult
1
2021
41087
0.010
Why?
Image Processing, Computer-Assisted
1
2000
778
0.010
Why?
Quality of Life
1
2007
3200
0.010
Why?
Lung Neoplasms
1
2003
2675
0.000
Why?
Lana's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)